ライフサイエンスコーパス: catheter-related bloodstream infection

1 603 catheters met the inclusion criteria for catheter-related bloodstream infection.

2 imple, and rapid method for the diagnosis of catheter-related bloodstream infection.

3 s indicated a substantial burden of arterial catheter-related bloodstream infection.

4 decreased ventilator-associated pneumonia or catheter-related bloodstream infection.

5 ought to evaluate the prevalence of arterial catheter-related bloodstream infection.

6 al catheters are an underrecognized cause of catheter-related bloodstream infection.

7 l site will help reduce the risk of arterial catheter-related bloodstream infection.

8 se of E. hermannii as the sole pathogen in a catheter-related bloodstream infection.

9 ng disruption on the risk for development of catheter-related bloodstream infection.

10 comparable for risk factors predisposing to catheter-related bloodstream infection.

11 l outcomes included local site infection and catheter-related bloodstream infection.

12 regnated and 160 tunneled) were analyzed for catheter-related bloodstream infection.

13 rs on the rates of catheter colonization and catheter-related bloodstream infection.

14 d in association with the catheters and with catheter-related bloodstream infections.

15 ntensive care unit (ICU) patients may affect catheter-related bloodstream infections.

16 e next-generation biocompatible solution for catheter-related bloodstream infections.

17 Ventilator-associated pneumonia and catheter-related bloodstream infections.

18 atheter-days, and studies providing data for catheter-related bloodstream infections.

19 nebacterium species are well-known causes of catheter-related bloodstream infections.

20 29 major catheter-related infections, and 23 catheter-related bloodstream infections.

21 s are effective in decreasing central venous catheter-related bloodstream infections.

22 sociated with a decrease in the incidence of catheter-related bloodstream infections.

23 s well as team approaches that can eradicate catheter-related bloodstream infections.

24 rvention was used to reduce the incidence of catheter-related bloodstream infections.

25 MB-P were significantly less likely to cause catheter-related bloodstream infection (0.24 vs. 0.82 pe

26 catheter was suspected as the source for the catheter-related bloodstream infection (0.70/1,000 cathe

27 1 per 1,000 ventilator-days; p < 0.001), and catheter-related bloodstream infections (1.0 vs 3.5 per

28 enous catheters from patients with suspected catheter-related bloodstream infection (a raised periphe

29 that the intervention significantly reduced catheter-related bloodstream infection after large-scale

30 phylococcus spp, remain the leading cause of catheter-related bloodstream infection, although an incr

31 ants routine use in patients at high risk of catheter-related bloodstream infection and central venou

32 To compare catheter-related bloodstream infection and colonization

33 stribution of microorganisms associated with catheter-related bloodstream infection and colonization

34 e primary outcome measure was a composite of catheter-related bloodstream infection and symptomatic d

35 catheter colonization and, more importantly, catheter-related bloodstream infection and warrants rout

36 Major catheter-related infection includes catheter-related bloodstream infections and clinical sep

37 isms in central venous catheter and arterial catheter-related bloodstream infections and colonization

38 animal pathogen, is commonly associated with catheter-related bloodstream infections and has evolved

39 lications of VADs but, with the exception of catheter-related bloodstream infections and thrombosis,

40 at occur in the intensive care unit, such as catheter-related bloodstream infections and ventilator-a

41 heter-associated deep vein thrombosis (DVT), catheter-related bloodstream infection, and catheter occ

42 tolerated, significantly reduces the risk of catheter-related bloodstream infection, and provides pro

43 catheters at each insertion site, number of catheter-related bloodstream infections, and the prevale

44 umber of experimental catheters used without catheter-related bloodstream infections; and j) number o

45 Catheter-related bloodstream infections are an important

46 Catheter-related bloodstream infections are associated w

47 Catheter-related bloodstream infections are associated w

48 duces the rates of catheter colonization and catheter-related bloodstream infection as compared with

49 duces the rates of catheter colonization and catheter-related bloodstream infections as compared with

50 In the 20 cases of catheter-related bloodstream infection associated with m

51 pared the rates of catheter colonization and catheter-related bloodstream infection associated with t

52 Catheters were studied for colonization and catheter-related bloodstream infection at removal; local

53 was no significant difference in the risk of catheter-related bloodstream infection between the subcl

54 was no significant difference in the risk of catheter-related bloodstream infections between the femo

55 was no significant difference in the risk of catheter-related bloodstream infections between the femo

56 was no significant difference in the risk of catheter-related bloodstream infections between the femo

57 nt studies show no difference in the rate of catheter-related bloodstream infections between the thre

58 ral venous catheters significantly decreased catheter-related bloodstream infections by 2.32% (95% co

59 tensive care unit, several measures, such as catheter-related bloodstream infections, can be signific

60 ssociated with a significantly lower risk of catheter-related bloodstream infections compared to the

61 omes assessed were catheter colonization and catheter-related bloodstream infection confirmed by cath

62 ary endpoints were major CRI with or without catheter-related bloodstream infection (CR-BSI) with chl

63 are efficacious in reducing the incidence of catheter-related bloodstream infection (CR-BSI); however

64 bicans biofilm formation and overall rate of catheter-related bloodstream infections (CR-BSIs) compar

65 Multiple studies have demonstrated that catheter-related bloodstream infections (CRBI) can be su

66 Our objective was to determine the risk of catheter-related bloodstream infection (CRBSI) and cathe

67 Catheter-related bloodstream infection (CRBSI) is a life

68 nce rates was preceded by the publication of catheter-related bloodstream infection (CRBSI) preventio

69 A catheter-related bloodstream infection (CRBSI) was suspe

70 The primary outcome was catheter-related bloodstream infection (CRBSI), analyzed

71 y outcomes were clinically diagnosed sepsis, catheter-related bloodstream infection (CRBSI), and all-

72 The major complications of HPN were catheter-related bloodstream infections (CRBSIs) (1.7/10

73 Catheter-related bloodstream infections (CRBSIs) are ass

74 Intravenous (IV) catheter-related bloodstream infections (CRBSIs) cause s

75 Little is known about catheter-related bloodstream infections (CRBSIs) in this

76 are receiving home parenteral support (HPS), catheter-related bloodstream infections (CRBSIs) inflict

77 stimate the effect of US-guided insertion on catheter-related bloodstream infections (CRBSIs, primary

78 Catheter-related bloodstream infections decreased from 2

79 There were 36 episodes of catheter-related bloodstream infection, defined as a pos

80 The average catheter-related bloodstream infections density was 2.5

81 Catheter-related bloodstream infection developed in 7 pa

82 Documented catheter-related bloodstream infection did not occur (0%

83 still associated with an increased risk for catheter-related bloodstream infection due to nonferment

84 Catheter-related bloodstream infections due to Staphyloc

85 ical sepsis without bloodstream infection or catheter-related bloodstream infection during the ICU st

86 Current evidence on catheter-related bloodstream infection femoral risk, com

87 However, the risk of catheter-related bloodstream infections from femoral as

88 perimental catheters used that resulted in a catheter-related bloodstream infection; h) number of con

89 s examining the outcome of primary interest, catheter-related bloodstream infection, had a summary od

90 of control catheters used that resulted in a catheter-related bloodstream infection; i) number of exp

91 nated central venous catheters (CVCs) reduce catheter-related bloodstream infection in adults and chi

92 incidence of both catheter colonization and catheter-related bloodstream infection in patients at hi

93 ple-lumen catheters may substantially reduce catheter-related bloodstream infections in an intensive

94 ifampin are efficacious and safe in reducing catheter-related bloodstream infections in cancer patien

95 r prevention and diagnosis of central venous catheter-related bloodstream infections in the intensive

96 am stain and AOLC test in suspected cases of catheter-related bloodstream infection, in comparison wi

97 for prevention of catheter colonization and catheter-related bloodstream infection, including arteri

98 risk of major catheter-related infection and catheter-related bloodstream infection increased by more

99 ohort studies that reported the frequency of catheter-related bloodstream infections (infections per

100 We found no difference in catheter-related bloodstream infection (internal jugular

101 Prevention of catheter-related bloodstream infection is a basic object

102 al therapy should be considered if a femoral catheter-related bloodstream infection is suspected.

103 Catheter-related bloodstream infection is the greatest t

104 emoral and internal jugular for the risks of catheter-related bloodstream infection, major catheter-r

105 Among central venous catheter catheter-related bloodstream infection, nonfermenting Gr

106 In the US, hemodialysis catheter-related bloodstream infections occur at a rate

107 No episode of catheter-related bloodstream infection occurred in the 5

108 A total of 17 catheter-related bloodstream infections occurred during

109 Catheter-related bloodstream infections occurring in the

110 the nonimpregnated catheters, with a rate of catheter-related bloodstream infection of 0.25 and 1.28/

111 outcome was major device complications (ie, catheter-related bloodstream infection or catheter-relat

112 09-0.23] and 0.6% vs 1.0%, respectively, for catheter-related bloodstream infection [OR, 0.50; 95% CI

113 e associated with a significant reduction in catheter-related bloodstream infection (p = .03).

114 rred for catheter colonization (P = 0.57) or catheter-related bloodstream infection (P = 0.99).

115 The median rate of catheter-related bloodstream infection per 1000 catheter

116 dressing resulted in a reduced prevalence of catheter-related bloodstream infection (random effects r

117 The overall catheter-related bloodstream infection rate was 0.2 per

118 The catheter-related bloodstream infection rate was 5.4 and

119 ms has been shown to decrease central venous catheter-related bloodstream infection rate.

120 w of the literature to determine the risk of catheter-related bloodstream infections related to nontu

121 us Diseases Society of America definition of catheter-related bloodstream infection remains the most

122 Catheter-related bloodstream infection risk was comparab

123 for baseline characteristics were excluded, catheter-related bloodstream infection risk was comparab

124 ular and subclavian may, similarly, decrease catheter-related bloodstream infection risk, when compar

125 sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintain

126 ent population is, however, at high risk for catheter-related bloodstream infections that can result

127 There are 80,000 catheter-related bloodstream infections that occur annua

128 ers has been demonstrated to protect against catheter-related bloodstream infection, the applicabilit

129 ologies applied to preventing central venous catheter-related bloodstream infection to arterial cathe

130 te of vancomycin use or presumed episodes of catheter-related bloodstream infections treated with ant

131 The rate of definitive catheter-related bloodstream infection was 1.24 per 1000

132 vs. 87 of 382 [22.8 percent], P<0.001), and catheter-related bloodstream infection was 1/12 as likel

133 ative methods; and, for prospective studies, catheter-related bloodstream infection was confirmed by

134 For the purposes of this study, catheter-related bloodstream infection was defined as po

135 The occurrence of catheter colonization and catheter-related bloodstream infection was determined.

136 Catheter-related bloodstream infection was diagnosed in

137 Catheter-related bloodstream infection was reduced after

138 The number of catheter-related bloodstream infections was expressed as

139 The rate of catheter-related bloodstream infections was higher in th

140 reparation, catheter days, and prevalence of catheter-related bloodstream infection were abstracted.

141 rates of ventilator-associated pneumonia and catheter-related bloodstream infection were analyzed by

142 128 cases of suspected catheter-related bloodstream infection were assessed in

143 postoperative intra-abdominal infection, and catheter-related bloodstream infection were identified,

144 In the control group, 8 catheter-related bloodstream infections were caused by S

145 reventive strategy, and outcome (measured as catheter-related bloodstream infections) were gathered.

146 contain original data relevant to lessening catheter-related bloodstream infections, were nonrandomi

147 hough earlier studies showed a lower risk of catheter-related bloodstream infections when the interna